INVO Historical PE Ratio image   This INVO PE ratio history page last updated 5/18/2022
INVO PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/16/2022
1.56-0.23-0.61NA
Q4 2021
3/31/2022
2.640.03-0.63NA
Q3 2021
11/15/2021
3.30-0.24-1.26NA
Q2 2021
8/16/2021
4.25-0.17-1.38NA
Q1 2021
5/17/2021
4.08-0.25NANA
Q4 2020
3/30/2021
4.94-0.60NANA
Q3 2020
11/16/2020
3.06-0.36NANA
INVO Historical PE Ratio Chart
Data adjusted for INVO split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/16/2022
1.56-0.23-0.92NA
Q4 2021
3/31/2022
2.640.030.1222.0
Q3 2021
11/15/2021
3.30-0.24-0.96NA
Q2 2021
8/16/2021
4.25-0.17-0.68NA
Q1 2021
5/17/2021
4.08-0.25-1.00NA
Q4 2020
3/30/2021
4.94-0.60-2.40NA
Q3 2020
11/16/2020
3.06-0.36-1.44NA
Quotes delayed 20 minutes

Email EnvelopeFree INVO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
INVO Bioscience (INVO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

INZY PE Ratio History
IONS PE Ratio History
IOVA PE Ratio History
IPSC PE Ratio History
IQV PE Ratio History
IRIX PE Ratio History
IRMD PE Ratio History
IRTC PE Ratio History
IRWD PE Ratio History
ISEE PE Ratio History
On this page we presented the INVO PE Ratio History information for INVO Bioscience' stock. The average INVO PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 22.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average INVO PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this INVO PE ratio history result, against the recent PE: when this page was posted on 5/17/2022, the most recent closing price for INVO had been 1.54, and the most recent quarterly earnings result, annualized, was 0.12. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent INVO PE on 5/17/2022 based on annualized quarterly EPS was 12.8. Based on INVO's history, that recent PE is low relative to the historical average, with the recent PE 41.8% lower than the historical average PE across our data set for INVO Bioscience.

For self directed investors doing their due diligence on INVO or any other given stock, valuation analysis for INVO can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate INVO Bioscience PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for INVO. Thanks for visiting, and the next time you need to research INVO PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: WILC shares outstanding history, OXFD Options Chain, Funds Holding IGIH.

 

INVO PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.